| scholarly article | Q13442814 |
| P2093 | author name string | Li-Hua Chen | |
| Bo-Rong Pan | |||
| Xue-Song Liu | |||
| Bo-Quan Jin | |||
| Wei-Ning Han | |||
| Wen-Yong Wang | |||
| P2860 | cites work | Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics | Q24672792 |
| Differential expression of TRAIL-R3 and TRAIL-R4 in human pancreatic cancer | Q28201795 | ||
| Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells | Q28203099 | ||
| Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor | Q28203587 | ||
| The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 | ||
| Evidence that the human death receptor 4 is regulated by activator protein 1 | Q28206926 | ||
| Expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in rat testis during development | Q28575473 | ||
| Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma | Q30803679 | ||
| Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance | Q34144126 | ||
| Management of necrotizing pancreatitis | Q34512097 | ||
| Influencing factors of pancreatic microcirculatory impairment in acute panceatitis | Q34668333 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes | Q35866576 | ||
| Characteristics and mechanism of enzyme secretion and increase in [Ca2+]i in Saikosaponin(I) stimulated rat pancreatic acinar cells | Q36308572 | ||
| Presence and density of common bile duct microlithiasis in acute biliary pancreatitis | Q36308596 | ||
| Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. | Q36506415 | ||
| Identification, localization and morphology of APUD cells in gastroenteropancreatic system of stomach-containing teleosts | Q36506428 | ||
| KAI1 gene is differently expressed in papillary and pancreatic cancer: influence on metastasis. | Q36506438 | ||
| Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver | Q39686745 | ||
| Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. | Q40642496 | ||
| Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors | Q40729349 | ||
| T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma | Q40737415 | ||
| Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. | Q40742709 | ||
| COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells | Q40747791 | ||
| Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. | Q40749621 | ||
| Stress kinase inhibition modulates acute experimental pancreatitis | Q43073031 | ||
| Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death | Q43672238 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer | Q43759157 | ||
| Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. | Q43891833 | ||
| The role of leucine-enkephalin on insulin and glucagon secretion from pancreatic tissue fragments of normal and diabetic rats | Q43907164 | ||
| Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. | Q43945239 | ||
| Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. | Q43966856 | ||
| Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines | Q44122252 | ||
| IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. | Q53673999 | ||
| TRAIL, Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer | Q56962490 | ||
| Reduced response of prostate cancer cells to TRAIL is modulated by NFkappaB-mediated inhibition of caspases and Bid activation | Q64378758 | ||
| Chemokines MCP-1 and RANTES in isolated rat pancreatic acinar cells treated with CCK and ethanol in vitro | Q73958106 | ||
| Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity | Q74410099 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro | Q74604121 | ||
| Adjuvant therapy in pancreatic cancer | Q77574356 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 334-337 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Localization of TRAIL/TRAILR in fetal pancreas | |
| P478 | volume | 9 |
| Q37076207 | Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes | cites work | P2860 |
Search more.